Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1983;67:162-171

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vestal, R. E.
Right arrow Articles by Halter, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vestal, R. E.
Right arrow Articles by Halter, J. B.

Circulation, Vol 67, 162-171, Copyright © 1983 by American Heart Association


ARTICLES

Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man

RE Vestal, CE Eiriksson Jr, B Musser, LK Ozaki and JB Halter

Theophylline is thought to act by inhibiting the activity of phosphodiesterase, with a resultant increase in intracellular cyclic AMP. However, this concept is largely based on in vitro studies using concentrations of theophylline which greatly exceed therapeutic plasma concentrations. To investigate the relationship of the cardiovascular and metabolic effects of theophylline to activation of the sympathetic nervous system, i.v. aminophylline was administered to six healthy males under basal conditions. Each subject received four infusions. Mean theophylline concentrations (+/- SEM) of 4.5 +/- 0.2, 10.0 +/- 0.5, 14.0 +/- 0.5 and 20.0 +/- 1.2 micrograms/ml were achieved. Plasma epinephrine increased 262% (from 29 +/- 4 to 105 +/- 14 pg/ml, p less than 0.01) and plasma norepinephrine increased 64% (from 190 +/- 18 to 312 +/- 51 pg/ml, p less than 0.05) during the high-dose infusion. The increases in circulating catecholamines were dose-related (p less than 0.001 by analysis of variance). Dose-related increases in heart rate, systolic blood pressure, plasma glucose, free fatty acids and insulin were also observed (p less than 0.001 by analysis of variance). Although the duration of total electromechanical systole (QS2) and left ventricular ejection time adjusted for heart rate fell during the aminophylline infusions, this positive inotropic response was not influenced by dose, except possibly the high dose. Echocardiographic ejection fraction was not changed by the aminophylline infusions. We conclude that the acute cardiovascular and metabolic effects of theophylline may be mediated in part by stimulation of the sympathetic nervous system.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. Rieg, H. Steigele, J. Schnermann, K. Richter, H. Osswald, and V. Vallon
Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
S. Takahashi, Y. Fujii, T. Hoshi, S.-i. Inomata, M. Miyabe, and H. Toyooka
Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs
Can J Anesth, March 1, 2000; 47(3): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-M. Loi, B. M. Parker, B. J. Cusack, and R. E. Vestal
Aging and Drug Interactions. III. Individual and Combined Effects of Cimetidine and Ciprofloxacin on Theophylline Metabolism in Healthy Male and Female Nonsmokers
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 627 - 637.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Minamino, M. Kitakaze, T. Morioka, K. Node, Y. Shinozaki BE, M. Chujo, H. Mori, H. Takeda, M. Inoue, M. Hori, et al.
Bidirectional Effects of Aminophylline on Myocardial Ischemia
Circulation, September 1, 1995; 92(5): 1254 - 1260.
[Abstract] [Full Text]